# The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer

> **NCT05551416** · — · RECRUITING · sponsor: **EDUARDO ALBENIZ** · enrollment: 1200 (estimated)

## Conditions studied

- Gastric Neoplasms
- Gastric Cancer
- Gastric Lesion

## Interventions

- **OTHER:** Identification of risk factors
- **OTHER:** Characterization of premalignant gastric lesions
- **OTHER:** Identification of biomarkers
- **OTHER:** Identification of gastric cancer hereditary predisposition

## Key facts

- **NCT ID:** NCT05551416
- **Lead sponsor:** EDUARDO ALBENIZ
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-09
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2023-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05551416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05551416, "The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05551416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*